GNI GROUP LTD.
Contact Us
About Us
About Us TOP
Message
Business Model
Main Products
Management Policy
Company Overview
Board of Directors
Main Group Structure
Office
Corporate governance
R&D
R&D TOP
Pipeline
Discovery Research
Research publications
Investor Relations
Investor Relations TOP
IR News
Information
IR Materials
IR Calendar
IR Email Subscription
Electronic Public Notices
Sustainability/ESG
Sustainability/ESG TOP
Sustainability Initiatives
ESG Data
Contact Us
Site Map
Privacy Policy
Terms of Use
ソーシャルメディアポリシー
Information
トップページ
Information
All
2026
2025
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2012/06/04
Notice of Subsidiary Company Establishment of Shanghai Genomics Inc.
2012/04/30
The China Pharmaceutical & Biotechnology Review, a monthly publication covering all aspects of the industry (2012 volume 58), published a panel discussion with Dr. Ying Luo and other Experts from biotechs and research institutes in China.
2012/03/16
Research Findings of F573 Published
2012/03/11
Drug Discovery World Asia 2012
2012/02/29
Notice for Manufacturing and Distribution Permission regarding IPF treatment drug, F647
2012/02/14
Announcement of the 11th Annual General Shareholder Meeting
2012/01/31
Notice for Exercise of the 35th Round of Stock Options in January, 2012 and Completion of its Exercise
2012/01/30
F351 Patents and Development Update
2012/01/12
Notice for Large Volume Exercise of the 35th Round of Stock Options
2012/01/12
The NIKKEI SANGYO SHINBUN, newspaper of Japan published an article describing the progress of F351 development in China.
<
15
16
17
18
19
20
21
22
23
>